Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AP
- Chemical substanceJ05AP09Dasabuvir
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 2 registrations
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
At a glance
- ATC code
- J05AP09
- ATC group
- Anti-infectives for systemic use
- Registers
- 5
- Historical lists
- 2
- Registrations
- 9
- With their own page
- 2
- Companies
- 6
All medicines with Dasabuvir
Human medicines from every register that match Dasabuvir by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
9 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Viekira Pak (Copackaged)Combination | United States | 250MG BASE; 12.5MG, 75MG, 50MG | tablet | Not marketed | Abbvie |
| Viekira XRCombination | United States | 200MG BASE; 8.33MG; 50MG; 33.33MG | tablet, extended release | Not marketed | Abbvie |
| EXVIERA 250 mg film-coated tablet | Saudi Arabia | Authorised | Abbvie Ireland NL B.V. | ||
| Holkira PakCombination | Canada | 250 MG + 12.5 MG + 75 MG + 50 MG | Kit, Tablet | Cancelled | Abbvie Corporation |
| Exviera | European Union | Withdrawn | AbbVie Ltd | ||
| Exviera 250 MG Comprimidos Recubiertos con Pelicula | Spain | 250 mg | comprimido recubierto con película | Withdrawn | Abbvie Deutschland Gmbh & Co. Kg |
| EXVIERA 250 mg | Romania | 250 mg | compr. film. | Status unknown | Abbvie Deutschland GMBH & Co. UK |
| EXVIERA 250mg | Romania | 250mg | compr. film. | Status unknown | Abbvie LTD |
| ViekiraCombination | Brazil | Cancelled | Abbvie Farmacêutica Ltda. |